文献速递主动脉疾病

EVAR术前肠系膜下动脉栓塞可减少瘤囊扩张与再干预且具成本效益

Preoperative Inferior Mesenteric Artery Embolization is a Cost-effective Technique that May Reduce the Rate of Aneurysm Sac Diameter Enlargement and Reintervention After EVAR.
PubMed 文献 · Ann Vasc Surg · 2019-06-12

该回顾性研究比较EVAR术前预防性栓塞肠系膜下动脉(IMA)的患者与未栓塞的历史对照队列,评估瘤囊直径增长、内漏与再干预率及管理费用。结果显示2年时对照组瘤囊扩张率、II型内漏率和动脉瘤相关再干预率均显著更高,而两组总体管理费用无差异。

要点

  • EVAR术前预防性IMA栓塞可能降低2年瘤囊扩张、II型内漏和再干预率。
  • 2年随访时两组患者总体管理费用无差异,提示该技术具成本效益。
  • 多因素分析支持上述结果,但样本量有限且为单中心回顾性设计。

核心结论

  • 预防性IMA栓塞是有效、可靠且具成本效益的技术,似乎可降低EVAR术后瘤囊直径扩张、II型内漏和再干预率。

研究设计与样本

  • 单中心回顾性研究,连续纳入2014年1月至2016年7月EVAR术前接受IMA栓塞的患者(组2)。
  • 对照组为2014年1月前接受EVAR且未行术前IMA栓塞的历史队列(组1)。

主要发现

  • 2年时对照组瘤囊直径扩张率显著高于栓塞组(27.9% vs. 4.3%,P = 0.025)。
  • 2年时对照组II型内漏率显著更高(53.1% vs. 18.2%,P = 0.012)。
  • 2年时对照组动脉瘤相关再干预率显著更高(31.1% vs. 8.1%,P = 0.013)。
  • 多因素分析证实上述结果。
  • 2年随访时两组患者管理总体费用无差异。

临床怎么用

  • 对接受EVAR的腹主动脉瘤患者,可考虑术前预防性IMA栓塞以减少II型内漏、瘤囊扩张和再干预。
  • 决策时可将该技术视为具成本效益的辅助手段,但需结合患者选择与中心经验。

局限性

  • 为单中心回顾性研究,栓塞组与历史对照组样本量较小(37例 vs. 46例)。
  • 对照组为历史队列,可能存在时间偏倚与选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Type II endoleaks are the most common complications after endovascular repair of abdominal aortic aneurysms (EVARs). Some studies have shown the benefit of preventive inferior mesenteric artery (IMA) embolization, but its efficacy and cost-effectiveness continue to be controversial. The aim of this study was to evaluate the efficacy of this procedure on the increase in aneurysmal sac diameter during follow-up. MATERIALS AND METHODS: All consecutive patients who underwent the embolization of the IMA before EVAR in our center, between January 2014 and July 2016, were included. We retrospectively compared the diameter of the aortic aneurysm sac, the rate of endoleak and reinterventions, and the theoretical cost of management between these patients (group 2) and a historical cohort of patients treated for EVAR before January 2014 who did not undergo prior IMA embolization (group 1). RESULTS: Two hundred twenty-four patients were retrospectively analyzed. After exclusion, we compared a group of 37 embolized patients with a control group of 46 patients. The rate of enlargement in the aneurysmal sac diameter was significantly higher in the control group at 2 years (27.9% vs. 4.3%, P = 0.025). The type II endoleak rate at 2 years was significantly higher in the control group (53.1% vs. 18.2%, P = 0.012), as was the aneurysm-related reintervention rate (31.1% vs. 8.1%, P = 0.013). Multivariate analysis confirmed these results. At 2 years of follow-up, there was no difference in the overall cost of patient management between the 2 groups. CONCLUSIONS: Preventive IMA embolization is an effective, reliable, and cost-effective technique that seems to reduce the rate of the aneurysmal sac diameter enlargement, type II endoleak, and reinterventions after EVAR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Vaillant M, Barral PA, Mancini J, et al. Preoperative Inferior Mesenteric Artery Embolization is a Cost-effective Technique that May Reduce the Rate of Aneurysm Sac Diameter Enlargement and Reintervention After EVAR. Ann Vasc Surg. 2019. PMID: 31200030. doi:10.1016/j.avsg.2019.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。